Parkinson’s disease (PD) represents one of the world’s greatest challenges to neurodegeneration, impacting millions worldwide. Central to its pathology lies alpha-synuclein protein and its aggregation as key players in both its onset and progression – this article explores this relationship by delving deeper into its intricate mechanisms underlying this correlation. Understanding Alpha-Synuclein Molecular Insight […]


